Use of defined TLR ligands as adjuvants within human vaccines

MS Duthie, HP Windish, CB Fox… - Immunological …, 2011 - Wiley Online Library
Our improved understanding of how innate immune responses can be initiated and how
they can shape adaptive B‐and T‐cell responses is having a significant impact on vaccine …

Immune adjuvant effect of molecularly-defined toll-like receptor ligands

DN Toussi, P Massari - Vaccines, 2014 - mdpi.com
Vaccine efficacy is optimized by addition of immune adjuvants. However, although adjuvants
have been used for over a century, to date, only few adjuvants are approved for human use …

Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond

A Lahiri, P Das, D Chakravortty - Vaccine, 2008 - Elsevier
Toll like receptors (TLRs) are a family of conserved pattern recognition receptors that
recognizes specific microbial patterns and allow the cell to distinguish between self and non …

Triggering TLR signaling in vaccination

D Van Duin, R Medzhitov, AC Shaw - Trends in immunology, 2006 - cell.com
Toll-like receptors (TLRs) are a family of pattern-recognition receptors that are an important
link between innate and adaptive immunity. Many established, as well as experimental …

TLR agonists as vaccine adjuvants targeting cancer and infectious diseases

M Luchner, S Reinke, A Milicic - Pharmaceutics, 2021 - mdpi.com
Modern vaccines have largely shifted from using whole, killed or attenuated pathogens to
being based on subunit components. Since this diminishes immunogenicity, vaccine …

Toll‐like receptors: the swiss army knife of immunity and vaccine development

JK Dowling, A Mansell - Clinical & translational immunology, 2016 - Wiley Online Library
Innate immune cells have a critical role in defense against infection and disease. Central to
this is the broad specificity with which they can detect pathogen‐associated patterns and …

Toll or toll-free adjuvant path toward the optimal vaccine development

KJ Ishii, S Akira - Journal of clinical immunology, 2007 - Springer
Successful vaccines contain an adjuvant component that activates the innate immune
system, thereby eliciting antigen-specific immune responses. Many adjuvants appear to be …

TLR-based immune adjuvants

F Steinhagen, T Kinjo, C Bode, DM Klinman - Vaccine, 2011 - Elsevier
This work describes the nature and strength of the immune response induced by various Toll-
like receptor ligands and their ability to act as vaccine adjuvants. It reviews the various …

Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics

A Kaur, J Baldwin, D Brar, DB Salunke… - Current opinion in …, 2022 - Elsevier
Until recently, the development of new human adjuvants was held back by a poor
understanding of their mechanisms of action. The field was revolutionized by the discovery …

Recent advances in the development of toll-like receptor agonist-based vaccine adjuvants for infectious diseases

JX Yang, JC Tseng, GY Yu, Y Luo, CYF Huang… - Pharmaceutics, 2022 - mdpi.com
Vaccines are powerful tools for controlling microbial infections and preventing epidemic
diseases. Efficient inactive, subunit, or viral-like particle vaccines usually rely on a safe and …